Talimogene laherparepvec — Uses, Dosage, Side Effects & Safety

Drug class: Oncolytic Virus Therapy (Immunotherapy)

Overview

Talimogene laherparepvec is a prescription medicine used to treat certain types of melanoma (a form of skin cancer) that cannot be removed by surgery and has spread to the skin or lymph nodes. It is an oncolytic virus therapy, meaning it uses a modified herpes simplex virus to infect and destroy cancer cells while stimulating the body’s immune system to attack the tumor. This medication is given as an injection directly into melanoma lesions. By targeting cancer cells, it helps shrink tumors and may slow the progression of the disease. Patients should know that Talimogene laherparepvec is not a cure for melanoma, but it can help control the disease and improve quality of life for some people. Key points: Treatment is administered by a healthcare professional, and regular follow-up is important to monitor for side effects and response to therapy.

Frequently Asked Questions about Talimogene laherparepvec

What is Talimogene laherparepvec used for?

It is used to treat unresectable melanoma that has spread to the skin or lymph nodes. It is not used for melanoma that has spread to internal organs.

How does Talimogene laherparepvec work?

It is a genetically modified herpes simplex virus that infects and destroys cancer cells while stimulating the immune system to attack tumors.

What are the most common side effects?

Common side effects include fatigue, chills, fever, nausea, and injection site reactions such as pain, redness, or swelling.

Can I receive this treatment if I am pregnant or breastfeeding?

No, Talimogene laherparepvec is not recommended during pregnancy or breastfeeding due to potential risks to the baby.

Is Talimogene laherparepvec a cure for melanoma?

No, it is not a cure. It helps control the disease and may shrink tumors, but it does not eliminate melanoma completely.

How is the medication given?

It is injected directly into melanoma lesions by a healthcare professional in a clinical setting.

What precautions should I take after receiving the injection?

Keep the injection site covered, practice good hygiene, and avoid close contact with immunocompromised individuals, infants, and pregnant women for at least 7 days.

Educational information only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.